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Background: Hypoglycemic and/or anti-hyperglycemic activities have been recorded with numerous plants,
many of which are used as traditional herbal treatments of diabetes. Albizzia Lebbeck Benth. stem bark have been
used in traditional medicine along with some preliminary reports on its hypoglycemic action. The aim of present
investigation was to evaluate the antidiabetic and antioxidant activities of methanolic extract of stem bark of
Albizzia Lebbeck Benth. in streptozotocin induced diabetic rats.
Methods: The powdered stem bark of Albizzia Lebbeck Benth.. was extracted with methanol (MeOH) using soxhlation
method and subjected to phytochemical analysis. The methanol/dichloromethane extract of Albizzia Lebbeck Benth.
(ALEx) was concentrated to dryness using Rotary Evaporator. Diabetes was experimentally induced in the rats by single
intraperitoneal administration of Streptozotocin (60 mg/kg). They glycemic control was measured by the blood
glucose, glycated heamoglobin and plasma insulin. The oxidative stress was evaluated in the liver and kidney by level
of antioxidant markers and various biochemical parameters were assessed in diabetic control and extract treated rats.
Results: Streptozotocin induced diabetic rats depicted the increased blood glucose levels, total cholesterol (TC),
triglycerides (TG), low density lipoprotein cholesterol (LDL-c), diminished level of high density lipoprotein cholesterol
(HDL-c) level and perturb level of antioxidant markers. Oral administration of MeAL at a concentration of 100, 200, 300
and 400 mg/kg b.w daily for 30 days results a momentous decrease in fasting blood glucose, glycated heamoglobin
and enhancement of plasma insulin level as compared with STZ induced diabetic rats. Furthermore, it significantly
(p < 0.05) decreased the level of TC, TG, and LDL-c, VLDL-c. While it increases the level of HDL-c to a significant
(p < 0.05) level. The treatment also resulted in a marked increase in reduced glutathione, glutathione Peroxidase,
catalase and superoxide dismutase and diminished level of lipid peroxidation in liver and kidney of STZ induced
diabetic rats. Histopathological studies suggest the diminution in the pancreatic, liver and cardiac muscle damage.
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Conclusion: Our research exertion clearly indicates the considerable antihyperglycemic, antihyperlipidemic, antioxidant
& pancreas/renal/hepatic/cardiac protective action of ALEx.
Keywords: Albizzia Lebbeck Benth, Bark, Diabetes, Streptozotocin, Hypolipidemic, Antioxidant, HistopathologyBackground
Diabetes mellitus (DM) is the most common endocrine dis-
order, and affects more than 100 million people worldwide
(6% of the population) and in the next 10 years it may affect
five times more people than it does now (World Health
Organization and American Diabetes Association). The
World Health Organization has pointed out that the pre-
vention of diabetes and its complications is not only a
major challenge for the future, but essential if health for all
is to be an attainable target, and strongly emphasize the op-
timal, rational use of traditional and natural indigenous
medicines (World Health Organization 1985, 1994).
There is an imbalance between radical generating and rad-
ical scavenging mechanisms i.e increased free radical pro-
duction or abridged activity of antioxidant defenses or both
results in oxidative stress. Oxidative stress is currently sug-
gested as the mechanism underlying diabetes and diabetic
complications [1]. Some of the researches have shown that
administration of streptozotocin (STZ) in the animals en-
gender diabetes mellitus and produce an assortment of re-
active oxygen species (ROS) as a result of glucose auto-
oxidation and protein glycosylation such as superoxide,
hydrogen peroxide, and hydroxyl radicals, that are either
formed by STZ itself over the short term or result from
induced hyperglycemia[2-4]. Additionally, there is a forma-
tion of advanced glycation end-products (AGE) by non-
enzymatic glycation reactions such as Amadori, Schiff base,
and Maillard, persuade the formation of free radical at
accelerated rates during the course of diabetes, and are asso-
ciated with the pathogenesis of chronic diseases such as
arthritis, atherosclerosis, and liver cirrhosis [5,6]. Conse-
quently, in recent times, antioxidant therapy has been
thought to be effectual for the prevention and treatment of
various diseases including diabetes, because oxidative stress
plays a key role in the pathogenesis of human diseases [7,8].
Albizzia Lebbeck Benth. is a deciduous tree with com-
pound leaves and flat oblong fruits. It is distributed
throughout India from the plains upto 900 m in the Hima-
layas. The bark and flowers of Albizia Lebbeck Benth. were
used to treat arthritis according to the Siddha system of
Medicine [9]. Several studies reported the traditional use of
A. Lebbeck Benth. such as the tribal people in Himachal
Pradesh and Kashmir use the plant to treat inflammation
[10-12], while the tribals of Tamilnadu utilizes the plant in
the treatment of bone fractures [13]. Diaorrhea, edema,
poisoning, asthma and bronchitis were also being cured by
the use of this plant [14,15]. Earlier studies also reportedthe beneficial effects of A. Lebbeck Benth such as the plant
reduces the level of histamine and raised the plasma corti-
sol in antigen challenged guinea pigs [16] and proves
advantageous activity in bronchial asthma patients. [17]. An
anti-inflammatory effect of methanolic extract of Albizia
Lebbeck bark was also reported. [18,19]. The antioxidant
potential of leaves of A. Lebbeck Benth. was reported by
Resmi et al (2006) [20]. Furthermore, a recent research
work has reported the hypoglycemic action of Albizzia
Lebbeck Benth. bark on diabetic rats. The study confirms
the improved glycemic control of Albizzia Lebbeck Benth.
bark [21]. A research work indicating the antidiabetic po-
tential of Albizzia Lebbeck bark in alloxan induced diabetic
mice was reported [22]. One report portraying the antidia-
betic activity of another important species of Albizzia
i.e. Albizzia odoratissima Benth. in alloxan induced diabetic
rats. The study depicted the hypoglycemic potential of
Albizzia odoratissima Benth. in diabetic rats [23]. The anti-
oxidant action of Albizzia Lebbeck leaves on alloxan induced
diabetic rats was evidenced by another study, confirming
the antioxidant activity of Albizzia Lebbeck Benth. on
alloxan induced diabetic rats [24]. Some other researches
that shows the leaves of plant has the antioxidant potential
[25] that can target the free radicals accountable for the
destruction of β-cells of pancreas. Consequently, aqueous
extract of flowers of Albizzia Lebbeck showed enhanced gly-
cemic control in alloxan induced diabetic rats [26].
Despite a long traditional utilization and some reports on
the hypoglycemic and antioxidant action of A. Lebbeck
Benth. in diabetes, no systematic phytochemical and phar-
macological research exertion has been carried out on
exhaustive research exertion on mode of action, antihy-
perlipidemic, pancreas, renal, liver and cardiac histopatho-
logical alterations, of the methanol/dichloromethane stem
bark extract of this impending plant. Therefore, we have
taken this research exertion in order to scrutinize plausible
mode of action of anti-diabetic potential and the anti-
oxidant action and of the A. Lebbeck Benth. bark.
Methods
Chemicals
Streptozotocin (STZ) was purchased from Sigma Aldrich,
St. Louis, USA. The kits for the assay of blood glucose
(GLU), total cholesterol(TC), triglyceride(TG), high density
Lipoprotein cholesterol(HDL–C), low density lipoprotein
cholesterol(LDL–C), hepatic glycogen, hepatic hexokinase,
glucose-6-phsophatase, fructose-1-6-bisphosphatase,
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dismutase(SOD), catalase (CAT), glutathione Peroxidase
(GSH-Px), reduced glutathione (GSH) diagnostic kits were
purchased from Span Diagnostics, Surat, India. Glycated
serum protein (GSP), blood urea nitrogen (BUN), and
creatinine (CRE) diagnostic kits were procured from
Accurex, India. Glibenclamide was a generous gift from
Ranbaxy Pharmaceutical Company, Gurgaon, India. All
other commercial reagents used were of analytical grade.
Animals
Male albino rats aged between 8-10 weeks (250-300 g) were
purchased from Indian Institute of Toxicological Research
(IITR), Lucknow, UP, India. Animals were kept in controlled
condition in animal house at an ambient temperature of
25-30°C and relative humidity of 55-60% and 12/12 h light/
dark cycle and were provided pellet diet along with water ad
libitum. The experimental protocol has been duly approved
by institutional animal ethical committee of Adina Institute
of Pharmaceutical Sciences (IAEC Reg. no. 1546/PO/a/11/
CPCSEA) and was performed according to the animal eth-
ical guidelines of CPCSEA, government of India.
Plant material
Fresh stem bark pieces of of A. Lebbeck Benth. were
collected from herbal garden of faculty of health sciences,
SHIATS, Allahabad, between September 2013-October
2013. The stem barks were identified and authenticated by
taxonomist, Botany department in FHS, SHIATS, Allahabad,
as stem barks of A. Lebbeck. A voucher specimen of the
plant (Ref no. FHS/PHCD/ALB/2013-2014/188) has been
deposited in the University’s Botany department herbarium.
Preparation of plant extracts
The A. Lebbeck Benth. stem barks were chopped into
small pieces, powdered, air-dried, sieved (#40) and stored
in air tight container at room temperature. Two kilogram
of powdered plant material was soaked in 4 L of metha-
nol/dichloromethane in a glass jar for two days at room
temperature. The mixture was then subjected to the ma-
ceration. The solvent was then filtered with Whatman No.
1. The filtration was repeated 4-5 times until the extract
depicts no faint discoloration. The yield of the methanol/
dichloromethane extract was found to be 10.82% w/w
(132 g). Five grams of this extract were dissolved in 1 mL
of dimethyl sulfoxide (DMSO) and then the solution
adjusted to 100 mL with distilled water. The extract was
further subjected to concentration using a rotary evapor-
ator (Buchi, India) under reduced pressure. The extract
was freeze dried for further phytochemical screening.
Preliminary phytochemicals studies
The extract was subjected to various phytochemicals
tests to determine the active constituents present in thecrude methanol/dichloromethane leaves extracts of stem
bark of A. Lebbeck Benth.
Acute toxicity study
Acute oral toxicity study was performed according to
the 423 guidelines (Acute toxicity class method) lay
down by OECD (Organisation of Economic Cooper-
ation and Development). Healthy male albino rats were
randomly divided into eight groups with 6 animals in
each group. The animals were kept fasting overnight
with supplementation of water, thereafter with metha-
nolic/dichloromethane extract of A. Lebbeck Benth.
stem bark with increasing doses (100, 200, 300, 400,
500, 600, 700 & 800 mg/kg body weight) with the aid
of intragastric tube in order to determine the safe
doses by up and down staircase method [27]. The
animals were scrutinized continuously for 1 h, then
repeatedly for 4 h and later at the end of 24 h for
general behavior, autonomic and neurological profiles.
Thereafter, one group was administered high dose of
A. Lebbeck Benth. extract orally once daily for 20 days
and observed for any lethality and death.
Induction of diabetes
Wistar rats were injected intraperitoneally with STZ
dissolved in 0.1 M citrate buffer (pH = 6.5) at 60 mg/kg.
Animals of control group were received equal volume
of vehicle. After 48 hours of STZ injection, blood glu-
cose of the induced rats was estimated. The rats depict-
ing FBG ≥ 230 mg/dL considered to be diabetic.
Experimental design
A total of 30 male albino wistar rats were utilized and
the animals were randomly divided into 7 groups of 5
animals in each group:
Group I- Normal rats (untreated with dimethylsulfoxide,
[DMSO, 3 ml/kg])
Group-II- Diabetic control (administered with
Streptozotocin (STZ)
Group-III- Diabetic control + A. Lebbeck Benth. stem
bark (ALEx) (100 mg/kg body weight)
Group –IV- Diabetic control + A. Lebbeck Benth. stem
bark (ALEx) (200 mg/kg body weight)
Group-V- Diabetic control + A. Lebbeck Benth. stem
bark (ALEx) (300 mg/kg body weight)
Group-VI- Diabetic control + A. Lebbeck Benth. stem
bark (ALEx) (400 mg/kg body weight)
Group-VII- Diabetic control + Glibenclamide (1 mg/kg
body weight)
The extract was administered to the respective groups
through oral route using intragastric tube for 45 days.
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Rats of the different groups were fasted overnight and the
blood was withdrawn by retro orbital puncture under light
and under anesthesia. Blood was withdrawn from the rats
on the 1st, 22nd and 45th day after the induction of dia-
betes to assess the blood glucose and plasma insulin level
by glucose oxidase method [28] and modified method of
Herbert et al. (1965) [29] respectively. The alteration in
the body weight was observed throughout the therapy in
the experimental animals.
At the termination of treatment i.e 45 days, animals
were deprived of food for overnight. Activities of hepatic
hexokinase, glucose-6-phsophatase, fructose-1-6-bispho-
sphatase, glucose-6-phosphate were assayed according
to the method of Branstrup et al (1957) King (1965),
Gancedo and Gancedo (1971) and Robert Langdon (1966),
respectively [30-33]. The lipid parameters viz. total
cholesterol, HDL cholesterol and triglycerides were
evaluated according the method of Zlatkis et al. (1953),
Burnstein et al. (1970) and Foster and Dunn (1973),
respectively [34-36]. Level of serum LDL cholesterol
and VLDL cholesterol were estimated according to the
Friedewald formula [37]. Hepatic glycogen level was
assessed by the method given by Kemp and Van Hejnigen
(1954) [38]. The levels of lipid peroxidation (LPO) in the
tissues were evaluated by the method of Okhawa et al.
(1979) [39]. Level of superoxide dismutase (SOD) was
assayed by the method of Kakkar et al. (1984) [40]. The
level of catalase (CAT) enzyme was evaluated by the
method of Sinha et al. (1972) [41]. Glutathione Peroxidase
(GSH-Px) was assayed by the method given by Rotruck
et al. (1973) [42]. Level of reduced glutathione (GSH) was
assessed by the method of Ellman (1959) [43].
Levels of blood urea nitrogen (BUN), glycated serum
protein (GSP) and creatinine (CRE) in serum wereTable 1 Effect of methanol/dichloromethane extract of Albizz
in normal & STZ induced diabetic treated rats
Groups
Normal rats (untreated with dimethylsulfoxide, [DMSO]) Group 1
Diabetic control (administered with Streptozotocin (STZ) Group 2
Diabetic control + (ALEx) (100 mg/kg body weight) Group 3
Diabetic control + (ALEx) (200 mg/kg body weight) Group 4
Diabetic control + (ALEx) (300 mg/kg body weight) Group 5
Diabetic control + (ALEx) (400 mg/kg body weight) Group 6
Diabetic control + Glibenclamide (1 mg/kg b wt.) Group 7
The data are expressed as mean ± SEM. (n = number of animals in each group = 5).
ns = non-significant, STZ = Streptozotocin.
*p < 0.05 is considered as significant when compared to the control group (0 h).
**p < 0.001 is considered as very significant when compared to the control group (0
***p < 0.001 is considered as extremely significant when compared to the control gevaluated according to the manufacturer’s instructions
provided in diagnostic kits.
Production of liver and kidney homogenate
For the estimation of the antioxidant level, the rats of the
respective groups were kept overnight fasted. All the rats
were decapitated and an abdominal incision was per-
formed, in order to harvest liver and pancreas. The whole
organs were thoroughly cleaned with chilled normal saline
on ice. A 10% (w/v) homogenate of the liver and pancreas
(0.03 M sodium phosphate buffer, pH-7.4) was prepared
with the help of Ultra-Turrax homogenizer maintaining
the speed at 9500 rpm.
Observation of general condition of rats
The overall general condition of rats such as psycho-
logical activity, food intake, water intake, urine output,
general locomotor activity, and skin infection were ob-
served every day. The parameters such as body weight and
food intake were determined every week.
Histological assessment of liver, kidney, pancreas and
heart sample by heamatoxylin eosin (H/E) staining
At the end of the treatment with the drug, all the rats of
different groups were sacrificed using mild anesthesia.
After collection of the blood samples, the liver, kidney,
pancreas and heart tissues were fixed in neutral formalin
solution for 48 hours, dehydrated by passing through
graded series of alcohol embedded in paraffin blocks.
4 μm thick sections were prepared using a semi-automated
rotator microtome.
Statistical analysis
Statistical analysis was performed using GRAPH PAD
Prism software package, Version 5.0. All the data wereia Lebbeck Benth. stem bark (ALEx) on blood glucose level
Blood glucose level in mg/dL at different time
interval of experimentation
At start (On 1st day) On 21st day On 45th day
83.78 ± 1.031 86.45 ± 1.003 90.00 ± 0.4292
305.4 ± 2.065 317.3 ± 1.612 372.3 ± 2.233
295.6 ± 1.842 250.1 ± 2.338ns 208.9 ± 0.5738ns
288 ± 0.4932 235.4 ± 0.8799ns 155.7 ± 0.4750
283 ± 0.7396 200.2 ± 0.3971* 125.2 ± 1.196*
282 ± 0.6635** 166.1 ± 0.7504** 91.68 ± 1.451***
281.1 ± 0.7859*** 157.4 ± 1.004*** 86.74 ± 1.701***
The comparisons were made by one way ANOVA followed by Dunnent’s test.
h).
roup (0 h).
Figure 1 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on blood glucose level in normal &
STZ induced diabetic treated rats. *p < 0.05 is considered as significant when compared to the control group (0 h); **p < 0.001 is considered as very
significant when compared to the control group (0 h); ***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
Figure 2 Effect of Albizia Lebbeck Benth. stem bark extract (ALEx) on histological profile of pancreas in normal, STZ-induced diabetic
untreated and STZ-induced diabetic treated wistar rats (Original magnification 10×, DXIT 1200 , Nikon, Japan). (i) NPALx: Heamatoxylin
and eosin (H/E) stained sections of pancreas of normal control rat portraying normal islet of langerhans shown by yellow arrows. (ii) STZP:
Pancreatic section of streptozotocin induced diabetic rat showing no/destroyed islet of langerhans and beta cells depicted by yellow arrows. (iii)
AL100: Pancreatic section of STZ-induced diabetic rats treated with ALEx at 100 mg/kg body wt. showing small number of islet of langerhans
(yellow arrows). (iv) AL200: Section of pancreas of STZ-induced diabetic rats treated with ALEx at 200 mg/kg body wt. portraying increased number of
islet of langerhans with small proportions of beta cells (yellow arrows). (v) AL300: Pancreas of diabetic rats treated with 300 mg/kg body wt. ALEx
depicting nearly normal islet of langerhans (yellow arrows). (vi) AL400: Sections of pancreas of diabetic treated rats with 400 mg/kg body wt. ALEx
showing normal islet of langerhans with numerous beta cells (yellow arrows). (vii) GLP: Pancreatic section of diabetic rats treated with Glibenclamide
showing normal pancreatic islet of langerhans with enhancement in the number of beta cells.
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Table 2 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on plasma insulin
level in normal & STZ induced diabetic treated rats
Groups Plasma Insulin level in μ at different time interval of experimentation
At start (On 1st day) On 21st day On 45th day
Normal rats (untreated with dimethylsulfoxide, [DMSO]) Group 1 18.22 ± 0.2077 17.17 ± 0.2059 16.39 ± 0.3864
Diabetic control (administered with Streptozotocin (STZ) Group 2 4.31 ± 0.1612 3.27 ± 0.1263ns 2.29 ± 0.1619ns
Diabetic control + (ALEx) (100 mg/kg body weight) Group 3 4.96 ± 0.09011 6.81 ± 0.03929ns 6.78 ± 0.1546
Diabetic control + (ALEx) (200 mg/kg body weight) Group 4 5.03 ± 0.1771 6.46 ± 0.1928 7.49 ± 0.1608
Diabetic control + (ALEx) (300 mg/kg body weight) Group 5 6.68 ± 0.1338 7.59 ± 0.1604 8.29 ± 0.1517*
Diabetic control + (ALEx) (400 mg/kg body weight) Group 6 7.79 ± 0.04665* 13.07 ± 0.2095*** 15.66 ± 0.1776***
Diabetic control + Glibenclamide (1 mg/kg b wt.) Group 7 7.89 ± 0.2871 13.81 ± 0.1706*** 16.64 ± 0.1518***
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
*p < 0.05 is considered as significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
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comparisons within groups were evaluated utilizing
independent student T-test and one way analysis of
variance (ANOVA). The value of p < 0.05 or p < 0.01
were considered to be statistically significant.
Results
Effect of ALEx on blood glucose level in normal & STZ
induced diabetic treated rats
The biochemical parameters of glycemic control in the
animals were summarized in Table 1 (Figure 1). The
intraperitoneal administration of streptozotocin (STZ)
resulted in nearly 4-fold increase of the fasting blood
glucose levels in the male/female diabetic Wistar rats.
The blood glucose level was measure at different timeFigure 3 Effect of methanol/dichloromethane extract of Albizzia Lebb
STZ induced diabetic treated rats. *p < 0.05 is considered as significant w
very significant when compared to the control group (0 h); ***p < 0.001 is
group (0 h).intervals during the research exertion viz. on the very
first day of induction of diabetes, at the middle of the
study i.e. on 21st day and at the finish of the experiment
i.e. on 45th day. It was observed that the gradual in-
crease in the dose of the ALEx, the blood glucose level
was improvised. At the end of 45 day period, ALEx
treated diabetic animals showed a significant reduction
of blood glucose nearly to the normal level compared
with the diabetic animals (p < 0.05) (Figure 2).
Effect of ALEx on plasma insulin level in normal & STZ
induced diabetic treated rats
The level of plasma insulin was measured at different
period during the experimentation. A significant de-
crease in the level of plasma insulin was observed ineck Benth. stem bark (ALEx) on plasma insulin level in normal &
hen compared to the control group (0 h); **p < 0.001 is considered as
considered as extremely significant when compared to the control
Table 3 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) during 120 min (2 h)
on OGTT in normal & STZ induced diabetic treated rats
Groups Time (h)
0 h 0.5 h 1 h 1.5 h 2 h
Normal rats (untreated with dimethylsulfoxide,
[DMSO]) Group 1
94.03 ± 1.193 135 ± 2.159 144.5 ± 1.385 155.9 ± 1.153 164.8 ± 1.785
Diabetic control (administered with Streptozotocin
(STZ) Group 2
265.7 ± 1.070 275.9 ± 1.205ns 286.4 ± 1.180ns 296.6 ± 0.9096ns 306.8 ± 0.9778
Diabetic control + (ALEx) (100 mg/kg body weight)
Group 3
255 ± 1.086 265 ± 0.8882ns 273.4 ± 1.024ns 283.1 ± 1.020ns 292 ± 0.8426ns
Diabetic control + (ALEx) (200 mg/kg body weight)
Group 4
245.2 ± 0.9767 254.8 ± 0.8538 263 ± 1.724** 271.8 ± 1.421 280.4 ± 1.148**
Diabetic control + (ALEx) (300 mg/kg body weight)
Group 5
234.2 ± 1.263 242.3 ± 1.136** 251.6 ± 0.8199** 261.7 ± 0.9516 270.8 ± 0.6865**
Diabetic control + (ALEx) (400 mg/kg body weight)
Group 6
217.1 ± 1.329*** 240.3 ± 0.4723** 250 ± 0.5276** 258 ± 0.7415 265.3 ± 0.6950***
Diabetic control + Glibenclamide (1 mg/kg b wt.)
Group 7
221.9 ± 0.6154 242.2 ± 0.6026** 252.1 ± 0.7302*** 261.1 ± 0.8815 269 ± 0.5970***
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
**p < 0.001 is considered as very significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
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and the level of plasma insulin was further decreased in the
untreated diabetic rats at the end of the study i.e. after
45 days. The treatment with the methanol/dichloromethane
extract of ALEx in a dose dependent manner. Treatment
with 400 mg/kg body weight of ALEx was shown to pro-
duce most significant (p < 0.05) effect on the level of plasma
insulin and amplify the level of plasma insulin nearly to the
normal as compared to the other doses of ALEx at the end
of research exertion (Table 2) (Figure 3).Figure 4 Effect of methanol/dichloromethane extract of Albizzia Lebb
normal & STZ induced diabetic treated rats. *p < 0.05 is considered as s
considered as very significant when compared to the control group (0 h); *
the control group (0 h).Effect of ALEx on OGTT in normal & STZ induced diabetic
treated rats during 120 min (2 h)
The results from the research exertion clearly indicated
that the of methanol/dichloromethane extract of Albizzia
Lebbeck Benth. stem bark (ALEx) (400 mg/kg body
weight) and Glibenclamide (1 mg/kg) reduced the blood
glucose level (significant hyperglycemia due to adminis-
tration of glucose load of 2 g/kg p.o) to a significant level
(p <0.05) after 2 h of oral administration as compared to
the diabetic control (Table 3, Figure 4).eck Benth. stem bark (ALEx) during 120 min (2 h) on OGTT in
ignificant when compared to the control group (0 h); **p < 0.001 is
**p < 0.001 is considered as extremely significant when compared to
Table 4 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on body weight
variation (grams) in normal & STZ induced diabetic treated rats
Groups Time (h)
1st Day 45th Day
Normal rats (untreated with dimethylsulfoxide, [DMSO]) Group 1 245.6 ± 4.479 297 ± 2.408
Diabetic control (administered with Streptozotocin (STZ) Group 2 249.8 ± 3.625 217.2 ± 3.527
Diabetic control + (ALEx) (100 mg/kg body weight) Group 3 245.6 ± 1.965ns 236 ± 2.702
Diabetic control + (ALEx) (200 mg/kg body weight) Group 4 247.4 ± 1.288 247.2 ± 2.417
Diabetic control + (ALEx) (300 mg/kg body weight) Group 5 247.2 ± 3.680 266 ± 0.7071
Diabetic control + (ALEx) (400 mg/kg body weight) Group 6 252.2 ± 2.245** 300 ± 0.5099**
Diabetic control + Glibenclamide (1 mg/kg b wt.) Group 7 249.8 ± 1.020 302 ± 0.7071***
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
**p < 0.001 is considered as very significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
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STZ induced diabetic treated rats
The body weight variation of the rats was observed at
the start and end of the research exertion. As it is obvi-
ous from the table (Table 4) (Figure 5), the weight of the
diabetic untreated rats was reduced to a significant level.
Weight of the ALEx treated rats was increased to a mo-
mentous level (p < 0.05) as compared to the normal rats.
Effect of ALEx on hepatic enzymes in normal & STZ
induced diabetic treated rats
Table 5 (Figure 6) portrays the alteration in the activities
of carbohydrate metabolizing enzymes in the liver of dia-
betic control and other experimental animals. The activ-
ities of hepatic hexokinase and glucose-6-phosphate
dehydrogenase (G6PD) were found to be decreased. On
the other hand, the level of gluconeogenic enzymes viz.
glucose-6-phosphatase and fructose-6-phosphatase were
significantly increased in the diabetic animals compared
to those in normal rats. Administration of differentFigure 5 Effect of methanol/dichloromethane extract of Albizzia
Lebbeck Benth. stem bark (ALEx) on body weight variation
(grams) in normal & STZ induced diabetic treated rats. *p < 0.05
is considered as significant when compared to the control group
(0 h); **p < 0.001 is considered as very significant when compared to
the control group (0 h); ***p < 0.001 is considered as extremely
significant when compared to the control group (0 h).doses of ALEx in diabetic rats reversed the alterations in
the hepatic enzymes such that animals received 400 mg/
kg body weight showed the significant improvement (p <
0.05) in all the hepatic enzymes alterations as compared
to the other doses.
Effect of ALEx on serum lipid profile in normal & STZ
induced diabetic treated rats
As Evident from the Table 6 that diabetic rats exhibited
significantly increased serum total cholesterol, VLDL
cholesterol, LDL cholesterol, triglycerides and decreased
level of HDL cholesterol and hepatic glycogen. Lipid
profile of the ALEx treated diabetic rats was significantly
improved (p < 0.05) as compared to the untreated dia-
betic rats (Figure 7).
Effect of ALEx on oxidative stress parameters in normal &
STZ induced diabetic treated rats
Table 7 clearly illustrates the effect of ALEx on the anti-
oxidant enzymes. A marked reduction was reported in the
level of superoxide dismutase (SOD), catalase (CAT),
Glutathione Peroxidase (GSH-Px), and reduced glutathi-
one (GSH) in the STZ induced diabetic rats along with a
discernible increase in the level of TBARS. Administration
of ALEx at different doses for the 45 days to STZ induced
diabetic rats significantly (p < 0.05) increased SOD, CAT,
GSH-Px levels with maximum effect seen at 400 mg/kg b.
wt. The enhanced level of TBARS was reversed to near
normal after administration of ALEx after administering
400 mg/kg b.wt of ALEx. It is pertinent to note that the
ALEx was found to be equipped with the antioxidant
effect in a dose dependent manner (Figure 8).
Effect of ALEx on renal function parameters in normal &
STZ induced diabetic treated rats
Blood urea nitrogen (BUN), serum creatinine (SCr) and
glycated serum protein (GSP), a measurement of kidney
Table 5 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on hepatic enzymes in
normal & STZ induced diabetic treated rats












Normal rats (untreated with
dimethylsulfoxide, [DMSO])
Group 1
0.214 ± 0.9152 0.176 ± 1.583 0.0282 ± 0.8437 0.128 ± 3.020
Diabetic control (administered with
Streptozotocin (STZ) Group 2
0.112 ± 1.056 0.273 ± 0.6038 0.0596 ± 1.492 0.058 ± 4.576ns
Diabetic control + (ALEx) (100 mg/kg
body weight) Group 3
0.13 ± 0.9104ns 0.241 ± 0.5943ns 0.0536 ± 0.6264ns 0.0614 ± 3.447
Diabetic control + (ALEx) (200 mg/kg
body weight) Group 4
0.142 ± 0.2780 0.219 ± 0.3499** 0.0496 ± 0.4148 0.0622 ± 3.083
Diabetic control + (ALEx) (300 mg/kg
body weight) Group 5
0.17 ± 0.5145 0.197 ± 1.831*** 0.0386 ± 0.7895** 0.0892 ± 7.843
Diabetic control + (ALEx) (400 mg/kg
body weight) Group 6
0.210 ± 0.8454*** 0.181 ± 0.8955*** 0.0298 ± 1.464 0.122 ± 3.408**
Diabetic control + Glibenclamide
(1 mg/kg b wt.) Group 7
0.212 ± 0.7552 0.172 ± 0.4005 0.0287 ± 0.8724 0.127 ± 1.711***
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
**p < 0.001 is considered as very significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
Ahmed et al. BMC Complementary and Alternative Medicine 2014, 14:243 Page 9 of 17
http://www.biomedcentral.com/1472-6882/14/243function test was evaluated during the experimentation.
As it is pertinent from Table 8 that the level of BUN,
SCr and GSP increased to a momentous level in the
STZ induced diabetic rats. Treatment with different
doses of ALEx has profound effect on the altered level
of renal function parameters. BUN, SCr and GSP level
were decreased to a significant (p < 0.05) level after
administration of an assorted doses of ALEx. While the
maximum reduction has been observed in the group of
rats received 400 mg/kg b.wt. of ALEx as compared to
the other doses (Figure 9).Figure 6 Effect of methanol/dichloromethane extract of Albizzia Lebb
induced diabetic treated rats. *p < 0.05 is considered as significant when
significant when compared to the control group (0 h); ***p < 0.001 is consideEffect of ALEx on histopathology of pancreas, kidney,
liver and heart
Pancreas
Normal control rat exhibited normal histological archi-
tecture. Many rounded normal proportions of islet of
langerhans were found all around the pancreatic acini.
Prominent nuclei with well arranged lobules with sur-
rounding islet cells were found in normal control rats
(Figure 2). Groups received STZ, demonstrated cellular
damage to the pancreatic acini and islets, which showed pan-
creatic β-cell damage and degeneration with asymmetricaleck Benth. stem bark (ALEx) on hepatic enzymes in normal & STZ
compared to the control group (0 h); **p < 0.001 is considered as very
red as extremely significant when compared to the control group (0 h).
Table 6 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth.. stem bark (ALEx) on lipid profile in
normal & STZ induced diabetic treated rats













Normal rats (untreated with
dimethylsulfoxide, [DMSO]) Group 1
128.9 ± 0.3926 53.19 ± 0.4878 27.18 ± 0.5619 77.57 ± 0.5943 49.7 ± 0.2316
Diabetic control (administered with
Streptozotocin (STZ) Group 2
273 ± 0.7544 14.25 ± 0.2791 105.81 ± 0.8731ns 193.1 ± 1.424 17.21 ± 0.09793
Diabetic control + (ALEx) (100 mg/kg
body weight) Group 3
201.8 ± 0.3189ns 15.26 ± 0.1843 82.56 ± 0.4372** 191.7 ± 0.4291 19.17 ± 0.1649
Diabetic control + (ALEx) (200 mg/kg
body weight) Group 4
188.1 ± 0.4720 28.27 ± 0.5883 81.11 ± 1.201 161.6 ± 0.5797ns 25.41 ± 0.4521
Diabetic control + (ALEx) (300 mg/kg
body weight) Group 5
162.8 ± 0.3100** 34.69 ± 0.5712* 43.94 ± 0.6629 131.3 ± 0.4677 38.41 ± 0.2578*
Diabetic control + (ALEx) (400 mg/kg
body weight) Group 6
141.4 ± 0.4808*** 43.74 ± 0.3495*** 30.09 ± 0.3958*** 93.57 ± 1.389** 41.68 ± 0.3041***
Diabetic control + Glibenclamide
(1 mg/kg b wt.) Group 7
145.7 ± 0.5246 48.02 ± 0.1643 28.51 ± 0.7293 81.99 ± 0.5388 48.05 ± 0.1163
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
*p < 0.05 is considered as significant when compared to the control group (0 h).
**p < 0.001 is considered as very significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
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marked improvement of the cellular injure (Figure 2),
as evident from the partial restoration of islet cells,
reduced β-cell damage, more symmetrical vacuoles and
an increase in number of islet cells.
Kidney
Morphological features of kidney remains normal in the
control group like prominent glomeruli, collecting ducts,
tubules and ascending and descending loops. STZ-inducedFigure 7 Effect of methanol/dichloromethane extract of Albizzia Lebb
induced diabetic treated rats. *p < 0.05 is considered as significant when
significant when compared to the control group (0 h); ***p < 0.001 is consideDM group showed presence of crystal deposition on the
glomeruli along with destructed glomeruli and infiltra-
tion of red blood cells (Figure 10). Groups received the
ALEx demonstrated the reversal of these pathological
destructions as apparent by the cell regeneration and
removal of crystal deposition.
Liver
The liver cells of normal control groups showed eminent
hepatocytes with central vein along with portal triadeck Benth. stem bark (ALEx) on lipid profile in normal & STZ
compared to the control group (0 h); **p < 0.001 is considered as very
red as extremely significant when compared to the control group (0 h).
Table 7 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth.. stem bark (ALEx) on oxidative stress










Normal rats (untreated with
dimethylsulfoxide, [DMSO]) Group 1
10.3 ± 0.1642 86.24 ± 0.7028 12.51 ± 0.1523 56.23 ± 0.5273
Diabetic control (administered with
Streptozotocin (STZ) Group 2
2.67 ± 0.07218 25.28 ± 0.4598 6.274 ± 0.1402 24.58 ± 0.1815
Diabetic control + (ALEx) (100 mg/kg
body weight) Group 3
3.794 ± 0.1306 26.89 ± 0.3122ns 6.628 ± 0.08243 25.7 ± 0.1362
Diabetic control + (ALEx) (200 mg/kg
body weight) Group 4
6.366 ± 0.01965 38.08 ± 0.4018 7.28 ± 0.01304ns 35.69 ± 0.2022
Diabetic control + (ALEx) (300 mg/kg
body weight) Group 5
7.44 ± 0.1626** 58.61 ± 0.2086** 9.694 ± 0.1273 41.36 ± 0.5254**
Diabetic control + (ALEx) (400 mg/kg
body weight) Group 6
9.474 ± 0.1209** 75.88 ± 0.6258*** 11.64 ± 0.04104*** 52.71 ± 0.4298***
Diabetic control + Glibenclamide
(1 mg/kg b wt.) Group 7
10.41 ± 0.1322 84.3 ± 0.5113 12.53 ± 0.1955 54.52 ± 0.3057
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
**p < 0.001 is considered as very significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
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damaged central vein, hepatocytes and portal trial can
be clearly seen in the group received STZ. The damage
to the liver cells were reversed in the all the ALEx
treated groups.
Heart
Normal control group showed a regular arrangement of
cardiac myocytes. STZ-induced DM rats demonstrated a
large infarct area with prominent lymphocyte infiltrationFigure 8 Effect of methanol/dichloromethane extract of Albizzia Lebb
normal & STZ induced diabetic treated rats. *p < 0.05 is considered as s
considered as very significant when compared to the control group (0 h); *
the control group (0 h).and fibrosis. Administration of ALEx reversed these mor-
phological changes in dose dependent manner (Figure 12).
Discussion
The present research exertion was designed to evaluate
the prospective effects of Albizzia Lebbeck Benth. stem
bark extract (ALEx) on glycemic control, antioxidant
status and its histopathological changes on the liver,
pancreas, kidney and heart. STZ diabetic model is one
of the important and most widely accepted and utilizedeck Benth. stem bark (ALEx) on oxidative stress parameters in
ignificant when compared to the control group (0 h); **p < 0.001 is
**p < 0.001 is considered as extremely significant when compared to
Table 8 Effect of methanol/dichloromethane extract of Albizzia Lebbeck Benth.. stem bark (ALEx) on renal function
parameters in normal & STZ induced diabetic treated rats







Normal rats (untreated with dimethylsulfoxide, [DMSO]) Group 1 6.54 ± 0.1503 152.3 ± 0.5651 27.35 ± 0.1943
Diabetic control (administered with Streptozotocin (STZ) Group 2 13.63 ± 0.1404 313.9 ± 1.426 37.29 ± 0.1431
Diabetic control + (ALEx) (100 mg/kg body weight) Group 3 12.11 ± 0.02990ns 285.7 ± 1.548ns 34.54 ± 0.1297
Diabetic control + (ALEx) (200 mg/kg body weight) Group 4 10.53 ± 0.1070 204.1 ± 1.795 33.43 ± 0.1779ns
Diabetic control + (ALEx) (300 mg/kg body weight) Group 5 8.48 ± 0.1101** 181.9 ± 0.3565* 32.29 ± 0.1512**
Diabetic control + (ALEx) (400 mg/kg body weight) Group 6 7.586 ± 0.1244*** 162.2 ± 0.6422*** 30.24 ± 0.06719***
Diabetic control + Glibenclamide (1 mg/kg b wt.) Group 7 7.122 ± 0.03121*** 160.8 ± 0.3589*** 29.5 ± 0.1336
The data are expressed as mean ± SEM. (n = number of animals in each group = 5). The comparisons were made by one way ANOVA followed by Dunnent’s test.
ns = non-significant, STZ = Streptozotocin.
*p < 0.05 is considered as significant when compared to the control group (0 h).
**p < 0.001 is considered as very significant when compared to the control group (0 h).
***p < 0.001 is considered as extremely significant when compared to the control group (0 h).
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betes. At present, a growing apprehension has attracted
attention of many researchers to and has brought back
traditional and complementary medicine due to their
pharmacological and economic advantages [44-46]. Our
previous research work also depicts the protective effect
of one traditionally used polyherbal formulation against
the diabetes induced liver and pancreatic damage [47].
Streptozotocin enters the pancreatic β-cells through
one of the important glucose transporter known as
GLUT 2 and damages the β-cells by DNA alkylation.
Furthermore, the damage is also done by the productionFigure 9 Effect of methanol/dichloromethane extract of Albizzia Lebb
normal & STZ induced diabetic treated rats. *p < 0.05 is considered as s
considered as very significant when compared to the control group (0 h); *
the control group (0 h).of superoxide radicals inside the β-cells which are pro-
duced with the help of xanthine oxidase. In addition to
the following mechanism another important mechanism
by which the β-cells are partially destroyed are the for-
mation of nitric oxide free radicals. Therefore, free radi-
cals play an important role in the development of
diabetes mellitus by causing the partial destruction of
β-cells [48]. In view of that, we hypothesized that free radi-
cals scavenging properties of a compound can ameliorate
the diabetic conditions.
Flavonoids are naturally occurring phenolic compounds
that are found in plants. They are widely distributed ineck Benth. stem bark (ALEx) on renal function parameters in
ignificant when compared to the control group (0 h); **p < 0.001 is
**p < 0.001 is considered as extremely significant when compared to
Figure 10 Effect of Albizia Lebbeck Benth. stem bark extract (ALEx) on histological profile of kidney in normal, STZ-induced diabetic
untreated and STZ-induced diabetic treated wistar rats (Original magnification 40×, DXIT 1200 , Nikon, Japan). (i) NKALx: Heamatoxylin
and eosin (H/E) stained sections of kidney of normal control rats showing normal glomeruli with normal baseline and tubules (yellow arrows).
(ii) STK: Section of kidney of STZ-induced diabetic rats depicting destroyed glomeruli with fat deposition on baseline along with infiltration of
lymphocytes (yellow arrows). (iii) KAL100: Kidney section of diabetic rats treated with ALEx at dose of 100 mg/kg body wt. portraying improved
vasculature and glomeruli (yellow arrows). (iv) KAL200: Section of kidney of diabetic rats treated with 200 mg/kg body wt. of ALEx showing normal
tubules along with virtually improved structure of glomeruli. (yellow arrows). (v) KAL300: Kidney section of diabetic treated rats with 300 mg/kg body
wt of ALEx depicting nearly normal glomeruli (yellow arrows). (vi) KAL400: Section of kidney of diabetic rat received 400 mg/kg body wt. of ALEx
showing normal glomeruli with no infiltration of lymphocytes (yellow arrows). (vii)KGLIB: Section of kidney of the rat supplemented with Glibenclamide
showing normal glomeruli with improved structure of tubules (yellow arrows).
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products of plant origin such as fruits, vegetables, tea,
wine and cocoa [49]. In recent years much of the attrac-
tion was on the antioxidant activity of flavonoids, due to
their ability to reduce the free radicals formation and to
scavenge free radicals. There are strong experimental
evidences that show that patients with diabetes mellitus are
susceptible to increase in blood level of oxidants [50,51].
An enhancement of blood glucose level was observed
in the oral glucose tolerance test (OGTT) was consider-
ably greater in the STZ induced diabetic rats as com-
pared to the non-diabetic rats. The level of plasma
insulin was increased in the non-diabetic rats as com-
pared to the diabetic rats in which there is a decrease in
the plasma insulin level. Administration of ALEx at dif-
ferent dose noticeably enhanced the impaired glucose
tolerance in the STZ induced diabetic rats with improve-
ment in the plasma insulin level. Based on the above
results, the hypoglycemic action of the Albizzia Lebbeck
Benth.. stem bark extract may be due to the insulin like
action i.e performing its action at the peripheral level to
improve the cellular uptake of glucose or enhance theglycogenesis. Many of the plant and their extracts have
shown to exert hypoglycemic action through stimulation
of insulin release [52,53]. The hypoglycemic action of
the ALEx is comparable to the conventional sulfonylurea
i.e. Glibenclamide that is reported to enhance the insulin
release from the beta cells of pancreas though their acti-
vation. Therefore, it is presupposed that ALEx could be
accountable for potentiation of the pancreatic secretion
of insulin from regenerated β-cells by inhibiting ATP
sensitive K + channels like Glibenclamide for stimulation
of insulin from the pancreatic beta cells.
Diabetic state is characterized by a severe loss in body
weight because of loss or degradation of structural pro-
teins [54]. Due to insulin deficiency there is a marked
reduction in the protein content in the muscular tissue
due to proteolysis [55]. The reversal in loss of weight in
the ALEx treated diabetic rats group exhibited that
restoration of the weight loss may be due the reversal of
proteolysis, gluconeogenesis and glycogenolysis [56].
In experimental diabetes, there is a marked alteration
of the enzymes accountable for glucose metabolism.
Persistent hyperglycemia is the major factor responsible
Figure 11 Effect of Albizia Lebbeck Benth. stem bark extract (ALEx) on histological profile of liver in normal, STZ-induced diabetic
untreated and STZ-induced diabetic treated wistar rats (Original magnification 40×, DXIT 1200 , Nikon, Japan). (i) NLALx: Heamatoxylin
and eosin (H/E) stained sections of liver of normal control rats showing normal portal triad along with normal hepatocytes with central vein
(yellow arrows). (ii) STZL: Liver section of rats received streptozotocin depicting destructed portal trial, disarranged hepatocytes and central vein
(yellow arrows).(iii) ALEx100: Section of liver supplemented with 100 mg/kg body wt. of ALEx portaying improvement in structure of portal triad
(yellow arrows). (iv)ALEx200: Liver section of rats received 200 mg/kg body wt. of ALEx showing arranged hepatocytes (yellow arrows). (v) ALEx300:
Section of liver or diabetic rats treated with 300 mg/kg body wt. of ALEx depicting arranged central vein (yellow arrows). (vi) ALEx400: Liver of diabetic
rat showing normal portal traid, central vein and hepatocytes (yellow arrows). (vii) LGLB: Liver section of rat administered with Glibenclamide showing
normal microvasculature along with normal hepatocytes (yellow arrows).
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ment of diabetic complications such as neuropathy and
micro-vascular complications [57]. Hepatic Hexokinase
and glucose-6-phosphate dehydrogenase activities have
been found to be decreased in the diabetic rats, which
may be due to the insufficiency of insulin. Hexokinase is
one of the important enzyme responsible for phosphor-
ylation of glucose into glucose-6-phosphate [58].
Insufficiency of hexokinase results in decreased glycoly-
sis and a marked reduction in the utilization of glucose for
the production of energy. Oral administration of ALEx to
diabetic rats resulted in considerable increase in the activ-
ity of hexokinase in dose dependent manner (Table 5).
The activities of hepatic glucose-6-phosphatase as well
as fructose-1,6 biphosphatase were increased to a signifi-
cant extent in STZ induced diabetic rats. The above men-
tioned enzymes are the key regulators in gluconeogenic
pathway. The increased activities of the two enzymes may
be due to the increased synthesis of enzymes contributing
to the enhanced glucose production by the liver in the
period of diabetes [59]. In our research exertion, adminis-
tration of ALEx had a significant effect on the level of
glucose-6-phosphatase and fructose-1,6 biphosphatase,which decreased to considerable level in dose dependent
manner. Maximum effect was observed in 400 mg/kg
body weight. The reduction in the above two biochemical
enzymes portrays the sequential metabolic correlation be-
tween increased glycolysis and decreased glyconeogenesis.
In the pathogenesis of diabetes, lipid plays a significant
factor. Increased level of cholesterol and lipids in plasma
represent a risk factor for coronary artery disease [60].
Increased level of total cholesterol, triglycerides, low
density lipoprotein cholesterol (LDL-cholesterol), very
low density lipoprotein cholesterol (VLDL-cholesterol)
was observed in streptozotocin induced diabetic rats.
Hypercholesterolemia in the rats received streptozotocin
is caused by increased intestinal absorption and increased
cholesterol biosynthesis [54]. Treatment with ALEx
reduced the total cholesterol, LDL-c, VLDL-c and triglyc-
erides level to a significant extent in dose dependent
manner, while increasing the beneficial HDL level to a
considerable extent. It is assumed that ALEx may exert its
hypocholesterolemic effect either due to decreased intes-
tinal absorption or decreased cholesterol biosynthesis. The
lipoproteins in the diabetic rats are oxidized and may be
cytotoxic, which can be reversed by the administration of
Figure 12 Effect of Albizia Lebbeck Benth. stem bark extract (ALEx) on histological profile of heart in normal, STZ-induced diabetic
untreated and STZ-induced diabetic treated wistar rats (Original magnification 40×, DXIT 1200 , Nikon, Japan). (i) NHALx: Heamatoxylin
and eosin (H/E) stained sections of heart (oblique cut) of normal control rats showing well arranged cardiac myocytes and normal striations
(yellow arrows). (ii) STZH: Section of heart of STZ-induced diabetic rats depicting disarranged cardiac myocytes with destroyed striations (yellow
arrows). (iii) ALEx100: Cardiac section of rats received 100 mg/kg body wt. of ALEx portraying better striations (yellow arrows). (iv) ALEx200: Heart
section of diabetic rats administered with 200 mg/kg body wt. of ALEx showing improved arrangement of cardiac myocytes (yellow arrows).
(v) ALEx 300: Section of heart of diabetic rats supplemented with 300 mg/kg body wt. of ALEx, showing nearly normal cardiac myocytes and striations
(yellow arrows). (vi) ALEx400: H/E stained section of heart of diabetic rats received 400 mg/kg body wt. of ALEx depicting normal arrangement
of cardiac myocytes and normal striations (yellow arrows). HGLB: Heart section of diabetic rats administered with Glibenclamide portraying
normal cardiac myocytes (yellow arrows).
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ALEx recovered the imbalanced lipid profile of STZ in-
duced diabetic rats in dose dependent manner.
Antioxidant capacity is reduced to a significant extent
in the plasma of STZ-induced diabetic rats, due to the
higher requirement of antioxidants in order to regulate the
reactive oxygen species (ROS) homeostasis [62]. Neverthe-
less, enhanced plasma antioxidant capacity in conjunction
with reduced lipid peroxidation could be attained by
regular ingestion of rich source of antioxidant com-
pounds. In our research exertion, we examined the
antioxidant capacity of ALEx. ROS can be primarily
eliminated by essential free radical scavenger enzymes,
such as superoxide dismutase (SOD), catalase (CAT),
glutathione (GSH) and glutathione Peroxidase (GSH-Px).
As it is obvious from the Table 7 that activities of antioxi-
dant related enzymes were detiorated by administration
of streptozotocin (STZ). When the activities of these
important antioxidant enzymes were diminished, the
superoxide anion and hydrogen peroxide (H2O2) radical
are available in excess, prompting the production of
ROS and dissemination of lipid peroxidation. The level
of SOD, CAT, GSH, GSH-Px were diminished in all thetissue of diabetic individuals [63]. Supplementation of
ALEx in STZ induced diabetic rats protect, to certain
degree, further improvement in the activities of GSH,
GSH-Px, CAT and SOD in liver of the diabetic rats.
Diabetic nephropathy (DN) is one of the major micro-
vascular complications of diabetes mellitus. In our present
research study, the development of DN is confirmed by
significant enhancement in the level of blood urea nitro-
gen (BUN), glycated serum protein (GSP) and serum cre-
atinine (Scr). Supplementation of ALEx in dose dependent
manner improves the renal function parameters. Effect of
ALEx 400 mg/kg body weight on reducing oxidative stress
and renal function parameters was significantly (p < 0.05)
better than the other doses.
Histopathological examination of diabetic pancreas,
showed islet of langerhans with fatty infiltration and
damaged acini. Administration of ALEx restores the
morphological changes in the pancreas to normal. Simi-
larly, the microscopic sections of STZ-diabetic liver
demonstrated the damaged central vein and surround-
ing portal triad. Supplementation of ALEx at different
dose recovers the normal histology of liver. Further-
more, the damaged glomeruli, tubules, collecting ducts
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ney of STZ-induced diabetic rats. These destructive
morphological changes were upturned to normal in all
ALEx treated groups. Correspondingly, arranged cardiac
myocytes were observed in the ALEx supplemented
groups as compared to the toxic diabetic rats. Accord-
ing to the microscopic examinations, the severe hepatic,
renal, pancreatic and cardiac lesions induced by STZ
were significantly diminished and restored by adminis-
tration of ALEx at lower to higher doses.
Conclusion
The results of the present investigation indicate that
ALEx ameliorates the hypoglycemia mediated oxidative
stress as well as corrects the lipid profile, hepatic and
renal parameters, which was evidenced by improved gly-
cemic control, lipid, renal, hepatic as well as antioxidant
biochemical parameters. It can also be concluded that
ALEx is a good source of natural antioxidants, which
could be a valuable tool in controlling lipid peroxidation
and maintaining lipid and lipoproteins. The histological
and ultra-structural observations made on the pancreas,
liver, kidney and heart tissue substantiate that ALEx pro-
tects the oxidative damage of islets of langerhans, hepa-
tocytes, glomeruli and cardiac myocytes on account of
its antioxidant potential. Consequently, further studies
on the isolation of active principle (s) which exerts the
anti-diabetic, hepatic and renal protective effect from
ALEx are at the developmental stage in our laboratory.
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